Dr Yong Wei Peng is the research director and senior consultant from National University Cancer Institute, Singapore at the National University Hospital. Dr Yong obtained his medical degree and postgraduate training in University of Aberdeen, Scotland. After completing an oncology fellowship at the National University Hospital, he was awarded the A*star international clinical pharmacology fellowship at the University of Chicago. Upon his return to Singapore, he was awarded the Clinician Scientist Award to further his research into personalized therapy. In addition, Dr Yong leads the therapeutic arm of the Singapore Gastric Cancer Consortium and chairs the National Health Group Domain Specific Review Board. His clinical and research interests are gastrointestinal cancer and drug development.